Quinine is a standard drug for treating severe malaria in Africa, and it is also increasingly used to treat uncomplicated disease. However, failures of quinine therapy are common, and it is unknown if failures in Africa are due to drug resistance. Recent studies have identified associations between in vitro quinine sensitivity and polymorphisms in genes encoding putative transporters, including well-described polymorphisms in pfcrt and pfmdr1 and varied numbers of DNNND or DDNHNDNHNND repeats in microsatellite 4760 (ms4760) of the predicted sodium-hydrogen exchanger, pfnhe1. This study aims to better characterise the mediators of quinine response. It assesses associations between genetic polymorphisms, in vitro quinine sensitivity, and quinine treatment responses in Kampala, Uganda.
Citation: F.N. Baliraine, S.L. Nsobya, J. Achan, J.K. Tibenderana, A.O. Talisuna, B. Greenhouse and P.J. Rosenthal, Antimicrobial Agents and Chemotherapy. 2011, 55(2):615. DOI: 10.1128/AAC.00954-10.
Country: UgandaKeywords: Quinine | Severe malaria | Treatment | Drug Resistance
« Back to Publications